3.40
price down icon3.52%   -0.1242
 
loading
Genfit Adr stock is traded at $3.40, with a volume of 11,523. It is down -3.52% in the last 24 hours and down -2.02% over the past month.
See More
Previous Close:
$3.5242
Open:
$3.42
24h Volume:
11,523
Relative Volume:
1.36
Market Cap:
$175.88M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-4.6315
EPS:
-0.7341
Net Cash Flow:
-
1W Performance:
-2.30%
1M Performance:
-2.02%
6M Performance:
-33.93%
1Y Performance:
-4.76%
1-Day Range:
Value
$3.30
$3.50
1-Week Range:
Value
$3.30
$3.68
52-Week Range:
Value
$3.11
$6.4229

Genfit Adr Stock (GNFT) Company Profile

Name
Name
Genfit Adr
Name
Phone
-
Name
Address
-
Name
Employee
0
Name
Twitter
@genfit_pharma
Name
Next Earnings Date
2024-09-19
Name
Latest SEC Filings
Name
GNFT's Discussions on Twitter

Compare GNFT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
GNFT
Genfit Adr
3.40 175.88M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
483.49 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
625.60 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
583.62 35.60B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
266.83 34.53B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
274.78 29.15B 3.81B -644.79M -669.77M -6.24

Genfit Adr Stock (GNFT) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-20-21 Upgrade H.C. Wainwright Neutral → Buy
Jul-23-20 Upgrade Stifel Hold → Buy
Jun-25-20 Initiated BofA/Merrill Underperform
May-13-20 Downgrade Kepler Buy → Reduce
May-12-20 Downgrade Barclays Overweight → Equal Weight
May-12-20 Downgrade H.C. Wainwright Buy → Neutral
Oct-29-19 Reiterated B. Riley FBR Buy
Jun-25-19 Initiated Stifel Hold
Apr-24-19 Initiated SVB Leerink Outperform
Apr-22-19 Initiated Barclays Overweight
View All

Genfit Adr Stock (GNFT) Latest News

pulisher
Apr 01, 2025

European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading - TradingView

Apr 01, 2025
pulisher
Mar 28, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading - TradingView

Mar 28, 2025
pulisher
Mar 27, 2025

European Equities Traded in the US as American Depositary Receipts Edge Higher in Thursday Trading - TradingView

Mar 27, 2025
pulisher
Mar 26, 2025

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading - TradingView

Mar 26, 2025
pulisher
Mar 24, 2025

European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - TradingView

Mar 24, 2025
pulisher
Mar 18, 2025

European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - TradingView

Mar 18, 2025
pulisher
Mar 14, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Down for Week - TradingView

Mar 14, 2025
pulisher
Mar 06, 2025

European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading - TradingView

Mar 06, 2025
pulisher
Mar 05, 2025

European Equities Traded in the US as American Depositary Receipts Climb Higher in Wednesday Trading - TradingView

Mar 05, 2025
pulisher
Mar 03, 2025

European Equities Traded in the US as American Depositary Receipts Surge Higher in Monday Trading - TradingView

Mar 03, 2025
pulisher
Feb 28, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Remain Flat for Week - TradingView

Feb 28, 2025
pulisher
Feb 21, 2025

GENFIT annonce les résultats préliminaires de l’Offre de Rachat proposée aux porteurs d’OCEANEs 2025 et la Convocation de l’assemblée générale des porteurs d’OCEANEs 2025 - GlobeNewswire Inc.

Feb 21, 2025
pulisher
Feb 14, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Up 1% for Week - TradingView

Feb 14, 2025
pulisher
Feb 05, 2025

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading - TradingView

Feb 05, 2025
pulisher
Oct 09, 2024

European Equities Traded in the US as American Depositary Receipts Open Week Slightly Higher - MSN

Oct 09, 2024
pulisher
Oct 09, 2024

European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading - MSN

Oct 09, 2024
pulisher
Sep 26, 2024

European Equities Traded in the US as American Depositary Receipts Move Higher in Tuesday Trading - MSN

Sep 26, 2024
pulisher
Jun 10, 2024

GENFIT: Historic Milestone Achieved with U.S. FDA - GlobeNewswire

Jun 10, 2024
pulisher
Jun 30, 2023

Ipsen and GENFIT Announce Positive Results from Phase III ELATIVE trial of elafibranor in patients with primary biliary cholangitis, a rare cholestatic liver disease - Ipsen

Jun 30, 2023
pulisher
Dec 18, 2021

Ipsen und GENFIT schließen im Rahmen einer langfristigen globalen Partnerschaft eine exklusive Lizenzvereinbarung für Elafibranor ab, ein Phase-III-Asset, das für die Behandlung von primärer biliärer Cholangitis geprüft wird - Business Wire

Dec 18, 2021
pulisher
Dec 17, 2021

Ipsen and GENFIT Enter Into Exclusive Licensing Agreement for Elafibranor, a Phase III Asset Evaluated in Primary Biliary Cholangitis, as Part of a Long-Term Global Partnership - Business Wire

Dec 17, 2021
pulisher
Jun 27, 2019

The Daily Biotech Pulse: Verrica Rallies, Aclaris Flunked Hair Loss Study, 3 Biotechs To IPO - Yahoo Finance

Jun 27, 2019

Genfit Adr Stock (GNFT) Financials Data

There is no financial data for Genfit Adr (GNFT). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
Cap:     |  Volume (24h):